Esophagogastroduodenoscopy

Esophagogastroduodenoscopy has been studied in 12 papers since 2016: 1 trial and 10 observational studies in people, 1 review; 6 in the past year.

Exposure

12 papers study it6 findingsUpdated

See all 11 papers on esophagogastroduodenoscopy

At a glance

The findings reach people, from one lab or study. 3 independent labs in 2 countries.

“Patients with Prior EGD had a 2-fold increased odds of early-stage gastric cancer compared with No Prior EGD (adjusted odds ratio: 2.05; 95% confidence interval [CI]: 1.82-2.31).”
Impact of Prior Upper Endoscopy on Gastric Cancer Stage and Survival in Older AdultsThe American journal of gastroenterology2025doi:10.14309/ajg.0000000000003769

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 3 independent labs in 2 countries
  • Funders: National Cancer Institute and 1 more
  • 1 of 6 findings with company ties
  • Human trial1
  • Humans9

What did studies of esophagogastroduodenoscopy find?

1

Studies of esophagogastroduodenoscopy measured one outcome, early-stage gastric cancer.

Early-stage gastric cancer

upin humans1

1 study
  1. Esophagogastroduodenoscopy is linked with higher early-stage gastric cancer in humans (6-36 months before gastric cancer diagnosis) (adjusted odds ratio: 2.05; 95% CI: 1.82-2.31).

    Humans6-36 months before gastric cancer diagnosisn = 15,871

More on Early-stage gastric cancer

What is esophagogastroduodenoscopy linked with?

4

Studies link esophagogastroduodenoscopy with 4 measures, among them gastric adenocarcinoma, gastric precancerous conditions and gastric cancer mortality.

Gastric adenocarcinoma

upin humans1

1 study
  1. Esophagogastroduodenoscopy is associated with gastric adenocarcinoma in humans during colonoscopy within colorectal cancer screening (0.8% (3/377)).

    Humansduring colonoscopy within colorectal cancer screeningstomachone-timen = 377

More on Gastric adenocarcinoma

Gastric precancerous conditions

upin humans1+47%

1 study
  1. Esophagogastroduodenoscopy is associated with gastric precancerous conditions in humans during colonoscopy within colorectal cancer screening (46.9%).

    Humansduring colonoscopy within colorectal cancer screeningstomachone-timen = 377

More on Gastric precancerous conditions

Gastric cancer mortality

downin humans1

1 study
  1. Esophagogastroduodenoscopy is linked with a lower risk of gastric cancer mortality in humans (6-36 months before gastric cancer diagnosis) (adjusted subdistribution hazard ratio: 0.64, 95% CI: 0.64-0.69).

    Humans6-36 months before gastric cancer diagnosisn = 15,871

Mortality

downin humans1

1 study
  1. Esophagogastroduodenoscopy is linked with a lower risk of mortality in humans (6-36 months before gastric cancer diagnosis) (aHR 0.78, 95% CI 0.74-0.83).

    Humans6-36 months before gastric cancer diagnosisn = 15,871

What acts on esophagogastroduodenoscopy?

1

Studies name nonagenarians as acting on esophagogastroduodenoscopy.

Nonagenarians

downin humans1OR 0.86

1 study
  1. Nonagenarians are linked with lower esophagogastroduodenoscopy in humans (NVUGIB) (30% vs. 48%, p<0.001; OR 0.86 (95% CI, 0.83-0.89)).

    HumansNVUGIB

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 2Nov 2026: 05 papers in 12 months

See all 11 papers on esophagogastroduodenoscopy